By Tyler Durden
Nearly three weeks after Pfizer and BioNTech released data purporting to show that their COVID jab is safe and effective for children between the ages of 5 and 11, the two companies confirmed Thursday that they had officially asked the FDA to approve their jab for emergency use for children in that age group.
According to the NYT, should the FDA grant this approval, it would make another 28MM Americans (all young children) eligible for the jab. The FDA has reassured Pfizer that it will “move quickly” on the request. A meeting has been tentatively scheduled for Oct. 26 to review the data and consider the emergency approval. A decision on emergency approval is expected some time between Halloween and Thanksgiving.
Parents across the country are waiting on the FDA’s decision. Now that California has become the first state in the country to require children to be vaccinated to attend school (be it private or public), the FDA’s approval could spur similar measures from other states.
